The NBA's COVID-19 protocol is necessarily rigorous, but it's thus far had a disproportionate effect on teams' training staffs.
The state of play: The league's 153-page document includes myriad new responsibilities, with team employees in charge of testing, contact tracing and more.
Rural Americans are especially hesitant to receive a coronavirus vaccine, and only a highly tailored outreach campaign is likely to change that.
The big picture: Even as the coronavirus has surged throughout rural America, most people who live in those areas don’t see vaccination part of a social responsibility to help protect others.
Americans are more eager to get a coronavirus vaccine now that the process is underway, according to the latest installment of the Axios-Ipsos Coronavirus Index.
Why it matters: This is an encouraging sign, and an indication that at least some vaccine hesitancy was simple wait-and-see caution — not dug-in opposition.
The Trump administration is set to deliver new guidelines today that will get coronavirus vaccinations moving much faster.
Driving the news: New federal guidelines will recommend opening up the process to everyone older than 65, and will also aim to move doses out the door rather than holding some back.
Three Democratic lawmakers have announced they've tested positive for COVID-19 after sheltering with maskless colleagues during last week's siege at the U.S. Capitol.
Driving the news: Rep. Brad Schneider (D-Ill.) said wrote in a statement Tuesday that he has tested positive for the virus after the attack last week, during which he had to shelter in a crowded space with other lawmakers.
World Health Organization chief scientist Soumya Swaminathan warned Monday herd immunity is unlikely to be achieved this year despite COVID-19 vaccines being rolled out.
The big picture: Mass coronavirus vaccinations are under way in the U.S. and across the world. Moderna said Monday its vaccine would provide immunity against the virus for at least a year. But Swaminathan told a briefing even if immunity "happens in a couple of pockets, in a few countries, it’s not going to protect people across the world" in 2021. "It takes time to scale the production of doses," she said.
States across the U.S. are opening stadiums, fairgrounds, convention centers and other large spaces as COVID-19 vaccine "megasites" as they ramp distribution of the shots.
Driving the news: Many states are moving to the next phase of the biggest vaccination drive in history, making vaccines available to new groups, including seniors, teachers, first responders and other essential workers.
President-elect Joe Biden publicly received his second dose of the Pfizer coronavirus vaccine on Monday in Newark, Delaware.
Why it matters: Biden's effort to bolster public confidence in the vaccine, which has been found by the FDA to be safe and 95% effective, comes after an alarming number of Americans polled in December said they would reject a vaccine.
A new study of coronavirus patients discharged from a hospital in Wuhan, China, found that most participants had at least one symptom six months later, the New York Times reports.
Why it matters: The study, published in The Lancet, is a stark reminder that death isn't the only thing to fear from the virus.
President-elect Joe Biden said on Friday that when he takes office, he'll release nearly all available coronavirus vaccines for distribution, instead of holding some back for second doses.
Why it matters: This could help more people get a first dose of the vaccine sooner, and a person familiar with the administration's planning told WSJ that the decision won't change the timing between doses. But there's no guarantee that the policy won't delay second doses.